Inflammatory bowel disease: can omega-3 fatty acids really help?

S. Barbalho,R. Goulart,Karina Quesada,M. Bechara,Antonely de Cássio Alves de Carvalho

Published 2016 in Annals of gastroenterology : quarterly publication of the Hellenic Society of Gastroenterology

ABSTRACT

Adjuvants to the traditional therapy of inflammatory bowel disease (IBD) have been studied to enhance the efficacy of the treatment and improve patients’ quality of life. Omega-3 polyunsaturated fatty acids (ω3FA) have been associated with attenuation of the inflammatory responses in IBD, possibly acting as substrates for anti-inflammatory eicosanoid production, similar to prostaglandins and leukotrienes. ω3FA also act as substrates for the synthesis of resolvins, maresins and protectins, indispensable in resolving inflammation processes. These acids may influence the development or course of IBD by: reducing oxidative stress, production of tumor necrosis factor-α and proinflammatory cytokines; working as chemopreventive agents; and decreasing the expression of adhesion molecules. There are numerous controversies in the literature on the effects of ω3FA in the prevention or treatment of IBD, but their effects in reducing inflammation is incontestable. Therefore, more studies are warranted to elucidate the pathophysiological mechanisms and establish the recommended daily intake to prevent or induce remission in IBD patients.

PUBLICATION RECORD

  • Publication year

    2016

  • Venue

    Annals of gastroenterology : quarterly publication of the Hellenic Society of Gastroenterology

  • Publication date

    2016-07-01

  • Fields of study

    Medicine

  • Identifiers
  • External record

    Open on Semantic Scholar

  • Source metadata

    Semantic Scholar, PubMed

CITATION MAP

EXTRACTION MAP

CLAIMS

  • No claims are published for this paper.

CONCEPTS

  • No concepts are published for this paper.

REFERENCES

Showing 1-81 of 81 references · Page 1 of 1

CITED BY

Showing 1-82 of 82 citing papers · Page 1 of 1